angeliq 1 mg + 2 mg
bayer pharma ag - germania - combinatii (estradiolum + drospirenonum) - compr. film. - 1mg+2mg - combinatii de hormoni progestogeni si estrogeni progestative si estrogeni, combinatii fixe
diane-35 0,035 mg/2 mg drajeuri
bayer ag - ethinylestradiolum + cyproteronum - drajeuri - 0,035 mg/2 mg
diane-35 0,035 mg/2,0 mg
bayer pharma ag - combinatii - draj. - 0,035mg/2,0mg - antiandrogeni antiandrogeni si estrogeni
diane-35 0,035 mg/2 mg drajeuri
bayer ag - ethinylestradiolum + cyproteronum - drajeuri - 0,035 mg/2 mg
zoely 2,5 mg + 1,5 mg comprimate filmate
schering-plough central east ag - nomegestrolum + estradiolum - comprimate filmate - 2,5 mg + 1,5 mg
midiana 3 mg/0,03 mg comprimate filmate
gedeon richter plc - drospirenonum + ethinylestradiolum - comprimate filmate - 3 mg/0,03 mg
dimia 3 mg/0,02 mg comprimate filmate
gedeon richter plc - drospirenonum + ethinylestradiolum - comprimate filmate - 3 mg/0,02 mg
dimia comprimate filmate 3 mg + 0,02 mg
gedeon richter plc - comprimate filmate - 3 mg + 0,02 mg
tybost
gilead sciences ireland uc - cobicistat - infecții cu hiv - antivirale pentru uz sistemic - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
evotaz
bristol-myers squibb pharma eeig - cobicistat, atazanavir - infecții cu hiv - antivirale pentru uz sistemic - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 și 5.